AQR Apex UCITS Fund IAEFT EUR Acc

Register to Unlock Ratings
Performance History30/04/2024
Growth of 1,000 (GBP) Advanced Graph
AQR Apex UCITS Fund IAEFT EUR Acc
Fund-----
+/-Cat-----
+/-B’mrk-----
 
Key Stats
NAV
17/05/2024
 EUR 101.09
Day Change -0.24%
Morningstar Category™ Multistrategy EUR
ISIN LU1662495628
Fund Size (Mil)
17/05/2024
 USD 448.16
Share Class Size (Mil)
17/05/2024
 EUR 0.40
Max Initial Charge -
Ongoing Charge
13/05/2024
  1.85%
Investment Objective: AQR Apex UCITS Fund IAEFT EUR Acc
The investment objective of the Fund is to seek total returns commensurate with its long-term risk target. The Fund will allocate its assets to three investment sub-strategies, each sub-strategy having a distinguishable set of investment objectives and the Market Neutral Security Selection Strategy. There can be no assurance that the Fund will achieve its investment objective.
Returns
Trailing Returns (GBP)17/05/2024
YTD-
3 Years Annualised-
5 Years Annualised-
10 Years Annualised-
12 Month Yield -
Management
Manager Name
Start Date
Yao Ooi
01/02/2017
Andrea Frazzini
01/02/2017
Click here to see others
Inception Date
07/06/2022
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
Not BenchmarkedMorningstar EU Cau Gbl Tgt Alloc NR EUR
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNo
HedgingNo
OtherNot Specific
Portfolio Profile for  AQR Apex UCITS Fund IAEFT EUR Acc-
Morningstar Style Box®
Equity Style
Morningstar Style Box®
Fixed Income Style
Asset Allocation
  % Long% Short% Net Assets
Fixed Income
Effective Maturity-
Effective Duration-
Top 5 Regions%
No Data Available
Top 5 Sectors%
No Data Available
Top 5 HoldingsSector%
No Data Available
AQR Apex UCITS Fund IAEFT EUR Acc

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures